Skip to main navigation
Pharming Group N.V. Logo
  • Home
  • News & Events
    News Releases Events and Presentations
  • Stock
    Stock Quote & Chart Analyst Coverage
  • Corporate Governance
    Documents & Charters Board of Directors Executive Committee Committee Composition
  • Shareholder Services
    Investor FAQs Email Alerts Contact IR

News Releases

Apr 07, 2021
Pharming Group announces the filing of its 2020 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
Pharming Group N.V. announces the filing of its Annual Report on Form 20-F for the year ended 31 December 2020 with the U.S. Securities and Exchange Commission (SEC)
Apr 06, 2021
Pharming Group announces the publication of its 2020 Annual Report and convenes its 2021 AGM
Pharming Group N.V. announces the publication of its Annual Report for the year ended 31 December 2020. In addition, the Company’s 2021 Annual General Meeting (AGM) will be held at 16:00CET on Wednesday, 19 May 2021. The Notice to Convene, Explanatory Notes, meeting documents and Form of Proxy can
Mar 23, 2021
Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors
Pharming Group announces the intention to nominate Steven Baert, Leon Kruimer and Jabine van der Meijs as Non-Executive Directors to the Board. Their official appointments will be confirmed by the Company’s Annual General Meeting of Shareholders that will be held on 19 May 2021.
Mar 16, 2021
Pharming Group to Present at 31st Annual Oppenheimer Healthcare Conference
Pharming Group N.V. today announces that its Chief Executive Officer, Sijmen de Vries, will present at the 31st Annual Oppenheimer Healthcare Conference 2021 at 15:40-16:10 CET/10:40-11:10 EDT on 16 March 2021.
Mar 11, 2021
Pharming Group to Present at BioCapital Europe 2021
Pharming Group today announces that its Chief Executive Officer, Sijmen de Vries, will present at BioCapital Europe 2021 at 10:30 CET on 11 March 2021.
Mar 04, 2021
Pharming Group reports financial results for full year 2020
Mar 02, 2021
Pharming Group, in collaboration with Invitae Corporation, launches genetic testing program ‘navigateAPDS’ in US and Canada
Pharming Group, in collaboration with Invitae Corporation, announces the launch of a sponsored genetic testing program, navigateAPDS, designed to assist clinicians in identifying patients and their family members with activated PI3K delta syndrome (APDS), which may lead to earlier diagnosis.

Shareholder Tools

  • Print Page
  • Email Alerts
  • RSS
  • Investor FAQs
  • © Pharming Group N.V. 2021